Early postoperative changes of sphingomyelins and ceramides after laparoscopic sleeve gastrectomy
暂无分享,去创建一个
M. Aslan | E. Afşar | Sabriye Kaya | H. Özer | I. Aslan | Yaşar Çöpelci | M. Oruç
[1] E. Ravussin,et al. Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes. , 2018, Metabolism: clinical and experimental.
[2] M. Aslan,et al. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients. , 2018, Lipids.
[3] O. Santos,et al. Self-Regulation of Weight After Sleeve Gastrectomy , 2018, Behavior modification.
[4] Yu Cao,et al. The sphingomyelin synthase family: proteins, diseases, and inhibitors , 2017, Biological chemistry.
[5] M. Aslan,et al. Inhibition of neutral sphingomyelinase decreases elevated levels of nitrative and oxidative stress markers in liver ischemia–reperfusion injury , 2017, Redox report : communications in free radical research.
[6] Hannah Jia Hui Ng,et al. Early weight loss after laparoscopic sleeve gastrectomy predicts midterm weight loss in morbidly obese Asians. , 2016, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[7] J. Ussher,et al. Targeting ceramide metabolism in obesity. , 2016, American journal of physiology. Endocrinology and metabolism.
[8] H. Car,et al. Regulation of sphingomyelin metabolism , 2016, Pharmacological reports : PR.
[9] A. Mureşan,et al. Effects of sleeve gastrectomy on insulin resistance , 2016, Clujul medical.
[10] J. Ryder,et al. Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity , 2016, International Journal of Obesity.
[11] G. Shulman,et al. A Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents , 2015, Diabetes.
[12] Y. Hannun,et al. Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death* , 2015, Journal of Biological Chemistry.
[13] Karen Winters,et al. Overweight and Obesity: Prevalence, Consequences, and Causes of a Growing Public Health Problem , 2015, Current Obesity Reports.
[14] E. Livingston,et al. Long-term follow-up after bariatric surgery: a systematic review. , 2014, JAMA.
[15] A. Futerman,et al. Ceramide synthases as potential targets for therapeutic intervention in human diseases. , 2014, Biochimica et biophysica acta.
[16] B. Kingwell,et al. Plasma Sphingosine-1-Phosphate Is Elevated in Obesity , 2013, PloS one.
[17] M. Aslan,et al. Early Postoperative Changes of HDL Subfraction Profile and HDL-Associated Enzymes After Laparoscopic Sleeve Gastrectomy , 2013, Obesity Surgery.
[18] J. Horowitz,et al. Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide , 2012, Diabetologia.
[19] M. Górska,et al. Ceramide metabolism is affected by obesity and diabetes in human adipose tissue , 2012, Journal of cellular physiology.
[20] P. Schauer,et al. Gastric Bypass Surgery Reduces Plasma Ceramide Subspecies and Improves Insulin Sensitivity in Severely Obese Patients , 2011, Obesity.
[21] Y. Hannun,et al. Many Ceramides* , 2011, The Journal of Biological Chemistry.
[22] N. Basso,et al. First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis , 2011, Surgical Endoscopy.
[23] M. Gagner,et al. Changes in Lipid Profiles in Morbidly Obese Patients After Laparoscopic Sleeve Gastrectomy (LSG) , 2011, Obesity surgery.
[24] Y. Hannun,et al. Regulated Secretion of Acid Sphingomyelinase , 2010, The Journal of Biological Chemistry.
[25] K. Petersen,et al. Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.
[26] Arya M. Sharma,et al. A Review of Laparoscopic Sleeve Gastrectomy for Morbid Obesity , 2010, Obesity surgery.
[27] R. DeFronzo,et al. Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance , 2009, Diabetes.
[28] Henry Buchwald,et al. Interdisciplinary European Guidelines on Surgery of Severe Obesity , 2008, Obesity Facts.
[29] S. Summers,et al. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. , 2008, Endocrine reviews.
[30] M. Birnbaum,et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. , 2007, Cell metabolism.
[31] H Buchwald,et al. Inter-disciplinary European guidelines on surgery of severe obesity , 2007, International Journal of Obesity.
[32] Y. Hannun,et al. Altered Adipose and Plasma Sphingolipid Metabolism in Obesity , 2006, Diabetes.
[33] M. Shields,et al. Trends in adult obesity. , 2006, Health reports.
[34] T. Veenstra,et al. Phosphorylation of Ser24 in the Pleckstrin Homology Domain of Insulin Receptor Substrate-1 by Mouse Pelle-like Kinase/Interleukin-1 Receptor-associated Kinase , 2005, Journal of Biological Chemistry.
[35] J. Levy,et al. Use and abuse of HOMA modeling. , 2004, Diabetes care.
[36] Alfred H. Merrill,et al. De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway* , 2002, The Journal of Biological Chemistry.
[37] M. Lorenzo,et al. Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. , 2001, Diabetes.
[38] I. Batty,et al. Ceramide impairs the insulin-dependent membrane recruitment of Protein Kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells , 2001, Diabetologia.
[39] C. Schmitz‐Peiffer,et al. Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with Palmitate* , 1999, The Journal of Biological Chemistry.
[40] A. Brogi,et al. Induction of intracellular ceramide by interleukin‐1β in oligodendrocytes , 1997 .
[41] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[42] A. Nilsson,et al. The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. , 1969, Biochimica et biophysica acta.
[43] A. Gomez-Muñoz,et al. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. , 2016, Progress in lipid research.
[44] N. Basso,et al. Early Postoperative Insulin-Resistance Changes After Sleeve Gastrectomy , 2010, Obesity surgery.
[45] S. Summers,et al. Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.
[46] R. DeFronzo,et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. , 2004, Diabetes.
[47] A. Brogi,et al. Induction of intracellular ceramide by interleukin-1 beta in oligodendrocytes. , 1997, Journal of cellular biochemistry.